• Explore /
  • Poster
  • / Prevalence of HRR gene mutations in patients with metastatic castration-resistant prostate cancer: Germline results from the Latin-American observational study PROSPECT.

Prevalence of HRR gene mutations in patients with metastatic castration-resistant prostate cancer: Germline results from the Latin-American observational study PROSPECT.

Abstract Video & Slides Poster

Authors

null

Ray Manneh Kopp

Sociedad de Oncología y Hematología del Cesar, Valledupar, Colombia

Ray Manneh Kopp , Carmen Alaez Verson , Martin Angel , Arturo Delgado , Pedro H Isaacsson Velho , Alejandro Manduley , Melissa Barbieri , Carmen Vargas , Francisco Gonzalez , Pedro C. Barata

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Translational Research, Tumor Biology, Biomarkers, and Pathology

Clinical Trial Registration Number

NCT04962880

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr 226)

DOI

10.1200/JCO.2023.41.6_suppl.226

Abstract #

226

Poster Bd #

H13

Abstract Disclosures

Similar Posters

First Author: Daniel Triner

First Author: Mehmet Asim Bilen

First Author: Vivek Narayan

First Author: Anna Couvillon